Stephen George Dilly, President and CEO at Aimmune Therapeutics, Inc. (AIMT), sold 141,075 shares at $25.01 ($2.5M) on 2017-09-25, disclosed to the SEC on 2017-09-27.
Open-market sale of $2.5M AIMT by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 41,075 | $0 | 0.0% |
| 2 | $25.01 | 100,000 | $2.5M | 100.0% |
| Total | $17.73 avg | 141,075 | $2.5M | 100% |
| Filing → |
| SRRA | BUY | 2021-05-20 | $178K | — | Filing → |
| SGMO | SELL | 2020-03-20 | $210K | — | Filing → |
| SGMO | SELL | 2020-03-18 | $90K | — | Filing → |